Application Notes

Thermal stability buffer screening of therapeutic antibodies

Issue link: https://resources.nanotempertech.com/i/1050491

Contents of this Issue

Navigation

Page 3 of 3

4 Thermal unfolding experiments The mAbs were subject to a linear thermal ramp (1 °C/min, from 25 to 90 °C), and tryptophan fluorescence at 350 and 330 nm was collected at a rate of 10 datapoints per minute. Unfolding transition midpoints were determined automatically from the 2 nd derivative of the fluorescence ratio (F350/F330). References Adair JR, Howard PW, Hartley JA, Williams DG, Chester KA (2012) Antibody-drug conjugates - a perfect synergy. Expert opinion on biological therapy 12: 1191-1206 Yang X, Ambrogelly A (2014) Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies. Current opinion in biotechnology 30C: 225-229 NanoTemper Technologies GmbH Floessergasse 4 81369 Munich Germany Phone: +49 (0)89 4522895 0 Fax: +49 (0)89 4522895 60 info@nanotemper-technologies.com http://www.nanotemper-technologies.com © 2015 NanoTemper Technologies GmbH NanoTemper ® Prometheus ™ and nanoDSF ™ are registered trademarks. V02_2016-12-21

Articles in this issue

Links on this page

view archives of Application Notes - Thermal stability buffer screening of therapeutic antibodies